ALB and type 2 diabetes mellitus: This study gives new insights to the understanding of the reduced effectiveness of aspirin in T2DM and provides a rationale for an interventional trial to assess if albumin supplementation may improve aspirin responsiveness and positively affect the risk of experiencing a future cardiovascular event.